Poland· PL-100470239
Adtralza
A tralokinumab product containing tralokinumabum, registered in Poland by LEO Pharma A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tralokinumab is registered in 14 of 19 countries.
Countries holding a registration under ATC D11AH07 (tralokinumab), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Tralokinumab · ATC D11AH07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tralokinumab costs, country by country.
Normalised to the WHO defined daily dose (16.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tralokinumab · price per daily dose (16.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$34.49
The record
At a glance
URPL (Poland)- Active substance
- Tralokinumabum
- Manufacturer
- LEO Pharma A/S
- Country
- Poland (PL)
- ATC code
- D11AH07
- ATC class
- Tralokinumab
- Defined daily dose
- 16.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin03400930276136
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tralokinumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADTRALZALEO Pharma A/S, Ballerup
- BelgiumAdtralza 300 mgLeo Pharma
- SpainADTRALZA 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADALeo Pharma A/S
- IcelandAdtralzaLEO Pharma A/S*
- SwedenAdtralza 300 mg Injektionsvätska, lösning i förfylld injektionspennaLEO Pharma A/S
- CanadaADTRALZALEO PHARMA INC
- SwitzerlandAdtralza
- FinlandAdtralzaLeo Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Adtralza
- Iceland · Adtralza
- Liechtenstein · Adtralza
- Norway · Adtralza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa6b719b-2ad2-41e6-bd57-90cf7c559860 GET /v1/drugs/aa6b719b-2ad2-41e6-bd57-90cf7c559860?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "300 mg",
"packaging": "03400930276136 ¦ Rpz ¦ EU/1/21/1554/004 ¦ 145434\n2 wstrzykiwacze 2 ml\n¦ UR/Z/4c/178/24 - 03400930276136 ¦ UR/Z/4c/137/24 - 03400930276136\nRpz ¦ EU/1/21/1554/005 ¦ 145435\n6 wstrzykiwaczy 2 ml",
"substance": "Tralokinumabum 300 mg",
"common_name": "Tralokinumabum",
"pl_product_id": "100470239",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tralokinumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.